良性子宫切除时行双侧输卵管卵巢切除术对卵巢癌发病与死亡的影响
该研究基于加拿大安大略省1996-2010年195,282例良性子宫切除患者,中位随访16年,比较双侧输卵管卵巢切除术与保留卵巢的卵巢癌发病和死亡风险。结果显示双侧输卵管卵巢切除术显著降低卵巢癌发病(HR 0.23)和死亡(HR 0.30),20年绝对风险降低0.38%,≥50岁女性绝对风险降低0.62%。
要点
- 双侧输卵管卵巢切除术使卵巢癌发病风险降低77%(HR 0.23),死亡风险降低70%(HR 0.30)。
- 20年卵巢癌累积 incidence 为0.08% vs 0.46%,绝对风险降低0.38%,NNT 260。
- ≥50岁女性绝对风险降低0.62%,NNT 161。
核心结论
- 良性子宫切除时行双侧输卵管卵巢切除术可显著降低卵巢癌发病和死亡的相对与绝对风险。
- 人群平均风险估计需与双侧输卵管卵巢切除术的其他潜在影响权衡,以指导实践指南和患者决策。
研究设计与样本
- 基于人群的队列研究,纳入1996-2010年加拿大安大略省所有≥20岁行良性子宫切除的成年女性。
- 排除卵巢病变、既往乳腺癌或妇科癌症、遗传易感性证据者。
- 共195,282例患者,双侧输卵管卵巢切除术占24%,保留卵巢占76%,中位年龄45岁(IQR 40-51)。
- 采用逆概率治疗加权Fine-Gray竞争风险模型,调整人口学特征、妇科疾病和合并症。
主要发现
- 中位随访16年(IQR 12-20),548例(0.3%)发生卵巢癌,16,170例(8.3%)全因死亡。
- 双侧输卵管卵巢切除术与卵巢癌发病风险降低相关(HR 0.23;95%CI 0.14-0.38;P<.001)。
- 双侧输卵管卵巢切除术与卵巢癌死亡风险降低相关(HR 0.30;95%CI 0.16-0.57;P<.001)。
- 20年加权累积卵巢癌发病率:双侧输卵管卵巢切除术0.08%,保留卵巢0.46%,绝对风险降低0.38%(95%CI 0.32-0.45;NNT 260)。
- 限制于子宫切除时≥50岁女性,绝对风险降低0.62%(95%CI 0.47-0.77;NNT 161)。
临床怎么用
- 在为良性子宫切除患者提供机会性双侧输卵管卵巢切除术时,应告知其卵巢癌风险降低的绝对幅度(20年约0.38%,≥50岁约0.62%)。
- 决策需结合患者年龄、绝经状态及卵巢激素缺乏的潜在风险进行个体化权衡。
局限性
- 观察性设计可能存在残余混杂。
- 研究人群为加拿大安大略省特定人群,外推需谨慎。
- 未报告双侧输卵管卵巢切除术对非卵巢癌结局(如心血管、骨质疏松等)的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opportunistic bilateral salpingo-oophorectomy is often offered to patients undergoing benign hysterectomy to prevent ovarian cancer, but the magnitude of risk reduction obtained with bilateral salpingo-oophorectomy in this population remains unclear and must be weighed against potential risks of ovarian hormone deficiency. OBJECTIVE: This study aimed to quantify the relative and absolute risk reduction in ovarian cancer incidence and death associated with bilateral salpingo-oophorectomy at the time of benign hysterectomy. STUDY DESIGN: We performed a population-based cohort study of all adult women (≥20 years) undergoing benign hysterectomy from 1996 to 2010 in Ontario, Canada. Patients with ovarian pathology, previous breast or gynecologic cancer, or evidence of genetic susceptibility to malignancy were excluded. Inverse probability of treatment-weighted Fine-Gray subdistribution hazard models were used to quantify the effect of bilateral salpingo-oophorectomy on ovarian cancer incidence and death while accounting for competing risks and adjusting for demographic characteristics, gynecologic conditions, and comorbidities. Analyses were performed in all women and specifically in women of postmenopausal age (≥50 years) at the time of hysterectomy. RESULTS: We identified 195,282 patients (bilateral salpingo-oophorectomy, 24%; ovarian conservation, 76%) with a median age of 45 years (interquartile range, 40-51 years). Over a median follow-up of 16 years (interquartile range, 12-20 years), 548 patients developed ovarian cancer (0.3%), and 16,170 patients (8.3%) died from any cause. Bilateral salpingo-oophorectomy was associated with decreased ovarian cancer incidence (hazard ratio, 0.23; 95% confidence interval, 0.14-0.38; P<.001) and decreased ovarian cancer death (hazard ratio, 0.30; 95% confidence interval, 0.16-0.57; P<.001). At 20 years follow-up, the weighted cumulative incidences of ovarian cancer were 0.08% and 0.46% with bilateral salpingo-oophorectomy and ovarian conservation, respectively, yielding an absolute risk reduction of 0.38% (95% confidence interval, 0.32-0.45; number needed to treat, 260). After restricting to women aged ≥50 years at hysterectomy, the absolute risk reduction was 0.62% (95% confidence interval, 0.47-0.77; number needed to treat, 161). CONCLUSION: Bilateral salpingo-oophorectomy resulted in a significant absolute reduction in ovarian cancer among women undergoing benign hysterectomy. Population-average risk estimates derived in this study should be balanced against other potential implications of bilateral salpingo-oophorectomy to inform practice guidelines, patient decision-making, and surgical management.
引用
- Cusimano MC, Ferguson SE, Moineddin R, et al. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy. Am J Obstet Gynecol. 2021. PMID: 34563499. doi:10.1016/j.ajog.2021.09.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。